Overview of Diclofenac Hexal

Property	Description
Active Ingredient	Diclofenac (typically as the sodium or potassium salt)
Pharmacological Class	Nonsteroidal Anti-inflammatory Drug (NSAID)
Origin / Type	Synthetic (phenylacetic acid derivative)
Common Forms	Oral tablets, capsules, topical gels, injections
General Purpose	Relief of inflammation, pain, and fever

What Type of Medicine is Diclofenac Hexal?

Diclofenac Hexal is a trade name for a medicine containing the active ingredient Diclofenac, which is classified as a synthetic Nonsteroidal Anti-inflammatory Drug (NSAID). This classification places it within a group of fundamental agents used to manage inflammation, pain, and fever systemically or locally. Diclofenac is clinically recognized for its powerful anti-inflammatory properties and belongs to the phenylacetic acid class of NSAIDs, which provides it with a distinct chemical profile compared to propionic acid derivatives like Ibuprofen. The preparation is designated as a prescription-only medicine (POM) in many regions and is generally manufactured by Hexal AG.

The Composition and Available Forms of Diclofenac

The core active ingredient Diclofenac is often utilized in its salt forms (Diclofenac sodium or Diclofenac potassium) to improve stability and absorption characteristics. As a single-active ingredient product (monotherapy), it is manufactured in diverse dosage forms suited for different routes of administration. These forms include oral tablets (immediate or extended-release), capsules, suppositories, solutions for parenteral (injection) use, and topical gels. The salt form used influences the rate at which the active substance becomes available in the body, with potassium salts generally allowing for faster absorption.

General Purpose: Anti-inflammatory, Analgesic, and Antipyretic Action

The general therapeutic purpose of Diclofenac is to provide symptomatic relief through its three core physiological actions: it is anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing). These effects are rooted in the drug's function as a Cyclooxygenase Inhibitor, which interrupts the biological production of chemical messengers (prostaglandins) that mediate pain and swelling. Diclofenac is used for its efficacy in alleviating discomfort associated with these symptoms. This means the drug helps address the root cause of swelling and irritation at a cellular level, thereby reducing the associated pain.

Regulatory References

What side effects are possible with Diclofenac Hexal?

Possible Side Effects and Safety Information

Diclofenac is a Nonsteroidal Anti-inflammatory Drug (NSAID) whose safety profile is defined by official regulatory classifications that group adverse reactions by frequency and affected physiological system. The most commonly documented adverse effects include headache, dizziness, nausea, vomiting, dyspepsia, and an increase in liver enzymes.

Serious Adverse Reactions and Safety Patterns

Regulatory documents explicitly highlight the risk of serious, potentially fatal, adverse reactions primarily involving the cardiovascular and gastrointestinal systems.

Serious Gastrointestinal Events: Official warnings cover the potential for bleeding, ulceration, or perforation of the stomach or intestines. This risk may increase with dose and duration of use.
Serious Cardiovascular Thrombotic Events: A major regulatory focus is the increased risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke. This risk is also considered to increase with higher doses and longer duration.
Rare Skin Reactions: Very rarely, severe skin reactions such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are reported.

Population-Specific Safety Constraints

Official labeling mandates specific safety constraints for certain patient groups:

Older Adults: This population has a greater risk for serious gastrointestinal adverse events.
Cardiovascular Restrictions: The medicine is contraindicated in patients with established conditions such as congestive heart failure (NYHA Class II-IV) and ischaemic heart disease.
Pregnancy: Diclofenac is contraindicated during the third trimester of pregnancy due to the potential for fetal harm.

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section details the officially documented clinical signs, severe outcomes, and mandated emergency procedures for Diclofenac overdose, as established by governmental regulatory authorities.

Documented Manifestations and Severe Outcomes

Official regulatory sources note that an overdose may present with gastrointestinal disturbances (such as vomiting, epigastric pain, and hemorrhage) and Central Nervous System (CNS) effects (including headache, drowsiness, disorientation, and tinnitus).

Severe or life-threatening outcomes documented in the prescribing information include acute renal failure and liver damage (hepatic impairment), as well as convulsions or coma in extreme cases. Patients with pre-existing renal or hepatic impairment may experience increased severity.

Required Emergency Actions

Immediate medical attention is required for any suspected overdose. Individuals must contact emergency services immediately.

Management is strictly symptomatic and supportive, as no specific antidote is known for Diclofenac overdose. The official regulatory guidance notes that procedures like gastric decontamination (such as activated charcoal) may be considered by medical professionals. Treatment focuses on maintaining vital functions and addressing symptoms or complications like internal bleeding and potential organ damage.

Therapeutic Uses of Diclofenac Hexal

Main Uses of Diclofenac Hexal

Diclofenac Hexal belongs to a group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used to manage symptoms associated with inflammatory and degenerative conditions affecting the musculoskeletal system. The medication works by inhibiting the production of prostaglandins, which are chemicals in the body that signal pain and promote inflammation.

Acute and Chronic Inflammatory Conditions

This medication is commonly used to treat symptoms of various forms of arthritis and joint-related inflammation, including:

Rheumatoid arthritis: Chronic inflammation of the joints.
Osteoarthritis: Degenerative joint disease involving the breakdown of cartilage.
Ankylosing spondylitis: Chronic inflammation affecting the spine and large joints.
Acute gout attacks: Sudden and severe joint pain caused by urate crystals.

Soft Tissue Disorders and Injuries

Beyond joint conditions, Diclofenac Hexal is indicated for the management of pain and swelling resulting from soft tissue damage. This includes:

Post-traumatic inflammation: Swelling and pain following sprains, strains, or dislocations.
Post-operative pain: Management of inflammation and discomfort following surgical procedures.
Soft tissue rheumatism: Conditions such as tendinitis, tenosynovitis, bursitis, and periarthropathy.

Other Painful Inflammatory States

In some clinical contexts, the medication may be used to provide relief for other acute painful conditions where inflammation is a primary component, such as painful inflammatory conditions in gynecology (e.g., primary dysmenorrhea) or as supportive treatment in severe painful inflammatory infections of the ear, nose, or throat.

Benefits of Treatment

The primary benefit of Diclofenac Hexal is the reduction of inflammatory responses. By addressing the underlying inflammation, the medication helps to:

Reduce swelling: Decreasing fluid buildup in affected tissues and joints.
Improve mobility: Easing stiffness and allowing for better range of motion in affected limbs.
Relieve pain: Providing systemic or localized relief from moderate to severe discomfort associated with tissue injury or chronic disease.

Regulatory References

NIH MedlinePlus overview of Diclofenac

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclofenac Hexal?

This section outlines the official population eligibility and non-eligibility rules for medicines containing Diclofenac, strictly based on governmental regulatory information.

Contraindicated Populations (Must Not Use)

Category	Non-Eligibility Rule
Cardiovascular Disease	Established Congestive Heart Failure (NYHA II-IV), Ischaemic Heart Disease, Peripheral Arterial Disease, or Cerebrovascular Disease.
Gastrointestinal Risk	Active gastric or intestinal ulceration, bleeding, or perforation, or history related to previous NSAID use.
Allergy/Hypersensitivity	Known allergy to diclofenac, aspirin, or other NSAIDs that caused asthma, urticaria, or severe reactions.
Surgery/Organ Failure	Treatment of perioperative pain in the setting of CABG surgery; established severe hepatic or renal failure.

Restricted and Age-Group Use

Pregnancy: Use is contraindicated after 30 weeks gestation (third trimester). Use is generally not recommended in the first or second trimester unless clearly necessary.

Pediatric Use: Oral forms are generally not recommended for children under 14 years of age. Use is established for adolescents 14 years and older.

Conditional Use: Patients with mild to moderate renal or hepatic impairment, ulcerative colitis, Crohn’s disease, or mild heart failure (NYHA I) require strict caution and medical oversight, as indicated in prescribing information.

What should I know about interactions with other medicines?

The official regulatory profile for Diclofenac (the active ingredient in Diclofenac Hexal) details several documented interactions that may affect co-administered medicines, systemic exposure, or patient risk. These constraints are essential for defining the product's use.

Pharmacodynamic and Additive Risks

Interactions involving Additive Pharmacodynamic Risk highlight an increased potential for serious outcomes. Co-administration with Anticoagulants and Antiplatelets (including SSRIs and SNRIs) is officially documented to increase the risk of serious bleeding. Concomitant use with Alcohol and other systemic NSAIDs is associated with an increased risk of gastrointestinal adverse events. Diclofenac may also cause Pharmacodynamic Efficacy Antagonism, diminishing the intended blood pressure control and diuretic effects of medicines like ACE Inhibitors, ARBs, and Diuretics.

Pharmacokinetic and Exposure Modification

Pharmacokinetic Exposure alterations are documented with several drugs. Diclofenac can reduce the clearance of medicines such as Lithium, Methotrexate, and Digoxin, potentially leading to increased systemic concentrations of those agents. Conversely, strong enzyme inhibitors like Voriconazole are officially documented to significantly increase Diclofenac’s own exposure (Cmax and AUC).

Regulatory and Procedural Constraints

Use is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery. The risk of renal function deterioration during co-administration with RAAS-affecting drugs is noted to be heightened in elderly or volume-depleted patients. Furthermore, some specific oral formulations have regulatory requirements to be taken separated from food.

Mechanism of Action

Targeting the Prostaglandin Synthesis Pathway

Diclofenac Hexal exerts its primary action by competitively inhibiting the Cyclooxygenase (COX) enzymes, particularly COX-2, thereby limiting the conversion of arachidonic acid into prostanoid mediators like Prostaglandin E2 ( PGE2). This action directly limits the chemical output of the arachidonic acid cascade, which is associated with increased mediator release.

️ Modulating Nociceptive Signaling and Receptor Sensitivity

The drug modulates the nociceptive signaling system through two pathways: it prevents the PGE2-driven sensitization of peripheral receptors (hyperalgesia), and it utilizes a secondary mechanism involving the Nitric Oxide (NO) pathway to desensitize nerve endings. This combined action initiates signaling sequences that lead to the modulation of neural afferent activity.

Central Action on Thermoregulation

A key physiological effect occurs in the central nervous system, where the drug blocks PGE2 synthesis within the hypothalamus, the brain's temperature control center. By removing this pyretic mediator, the mechanism initiates mechanisms for heat dissipation and the adjustment of the elevated thermal set-point.

Dosage and Administration Information

How to Use Diclofenac Hexal

Administration of Diclofenac follows established principles to ensure consistent and controlled use. The drug is available in multiple forms that determine its proper route and dosing pattern, including oral tablets, topical gels, and parenteral (intravenous/intramuscular) injections.

Official Dosing and Administration

Usage of Diclofenac is guided by the principle of administering the lowest effective dose for the shortest duration necessary for clinical needs.

Administration Aspect	Administration Guidelines
Route Focus	Oral, Topical, Intravenous, Intramuscular, Rectal.
Dosing Range	Total daily oral dose for chronic conditions typically ranges from 100 mg to 200 mg, divided. The maximum daily dose for chronic oral use is generally 150 mg.
Frequency	Once daily for extended-release (ER) forms, or divided doses (two to four times daily) for immediate-release (IR) and delayed-release (DR) forms.

Procedural and Contextual Instructions

Specific procedural rules must be followed based on the formulation: Delayed-Release or Extended-Release tablets must be swallowed whole and should not be crushed, broken, or chewed. This instruction prevents unintended changes to the drug's release rate.

For Diclofenac oral powder used for acute treatment, the contents must be mixed with water only and taken on an empty stomach. Administration conditions also extend to specific populations, with instructions to initiate treatment at the low end of the dose range for older adult patients.

Recent Clinical Evidence

Research Evidence: Diclofenac Hexal

This section provides an overview of the research landscape and study patterns observed in studies for the drug diclofenac, as described in regulatory documents and peer-reviewed literature. It focuses on the structure of the evidence and the types of outcomes that have been monitored, without offering medical advice or treatment instructions.

Research Exploring Osteoarthritis and Rheumatoid Arthritis

Research exploring conditions characterized by fluctuating or episodic manifestations like osteoarthritis (OA) and rheumatoid arthritis (RA) primarily involves short-term randomized controlled trials (RCTs). These studies were applied in research contexts involving unstable symptoms in adult populations. Researchers specifically examined outcomes reflecting daily functioning or activity level, alongside patient-reported outcomes describing perceived discomfort.

In these research scenarios, trials monitored changes in scores for pain intensity and physical function over defined time intervals, typically ranging from a few weeks up to twelve weeks. Studies report how symptoms evolved in the observed populations where measurements were taken in comparison against an inactive substance (placebo). Research has explored comparative scenarios where measurements were taken against other standard agents, and findings indicated that the reported outcomes varied across studies.

Research Exploring Ankylosing Spondylitis and Acute Pain

Studies for ankylosing spondylitis (AS), a condition characterized by fluctuating manifestations, were studied for periods of increased symptom activity. Evidence from regulatory clinical programs describes how symptoms evolved in the observed populations related to spinal function. Some long-term studies examined changes in radiographic progression (spinal structure) over periods up to two years, and the findings were mixed.

In research scenarios involving conditions associated with acute or disruptive episodes, the evidence is derived from studies exploring short-term symptom changes, often in controlled settings like post-operative or post-trauma pain models. These trials primarily monitor outcomes related to physical discomfort over very short timeframes, sometimes only a few hours. Findings describe patterns observed in the studies where outcomes related to physical discomfort may vary across different salt formulations (e.g., potassium versus sodium) of the drug.

Key Evidence Gaps and Areas of Uncertainty

Despite a broad evidence base, evidence highlights what is known—and what is still uncertain. The primary limitation is that follow-up durations were limited in many core efficacy studies, meaning long-term outcomes are not fully characterized. Additionally, comparative evidence is lacking for some of the newer, alternative therapies. Evidence highlights what is known but research does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Diclofenac Hexal (FAQ)

Q: Does Diclofenac Hexal affect sleep?

Official safety documents report that effects on the central nervous system are possible when using medicines containing diclofenac. Reported adverse reactions in regulatory labeling include both insomnia (difficulty sleeping) and drowsiness.

Q: What are the signs that Diclofenac Hexal might be causing a problem with my liver?

While official labeling notes that increases in liver enzymes are possible, patient safety information also reports visible signs of potential liver issues. These signs may include the whites of the eyes or skin turning yellow, known as jaundice.

Q: Can Diclofenac Hexal be used for period pain (menstrual cramps)?

Yes, according to official indications, certain formulations of the active ingredient diclofenac are specifically approved and indicated for the treatment of dysmenorrhea, which is the clinical term for menstrual cramps.

Q: Can Diclofenac Hexal affect fertility in men or women?

Studies and official documents indicate that, like some other anti-inflammatory medicines, the use of diclofenac may temporarily interfere with ovulation. This effect could make it more challenging to conceive, but it is typically reversible once the medicine is stopped.

Q: What should I do if I miss a scheduled time for Diclofenac Hexal?

Regulatory guidance describes a procedure where the user continues with the next scheduled dose as planned. It is officially stated that the dose should not be doubled to compensate for the missed one.

Q: Do studies support the use of Diclofenac Hexal for back pain?

Official indications for diclofenac often include treatments for post-traumatic pain or conditions known as non-articular rheumatism (pain in soft tissues). However, official regulatory labeling may not explicitly list general back pain as a primary approved indication.

Q: Is there a certain amount of time I should not use Diclofenac Hexal for?

Official regulatory guidance stresses that the medicine should be used at the lowest effective dose for the shortest duration possible to reduce potential risks. For chronic conditions, regulatory information indicates that long-term use is subject to periodic, regular medical review.

Q: Can older adults use Diclofenac Hexal safely?

Official safety information advises caution for older patients, as they are considered to be at a greater risk for serious gastrointestinal adverse events (like bleeding). Due to these increased risks, official documents recommend treatment for older adults be initiated at the low end of the dose range.

Q: Are there any common foods or drinks that should be avoided with Diclofenac Hexal?

Regulatory warnings emphasize avoiding alcohol while using this medicine, as the combination increases the risk of serious gastrointestinal issues. Furthermore, specific formulations, such as the oral powder, have regulatory requirements to be mixed with water only and taken on an empty stomach.

Q: Does Diclofenac Hexal interact with herbal supplements like St. John's Wort?

Although St. John's Wort is not always listed specifically in interactions tables, regulatory documents indicate that the metabolism of diclofenac involves the CYP enzyme system. Supplements like St. John's Wort are known enzyme inducers that could potentially lower the effectiveness of diclofenac.

Q: Are there any official warnings about driving while using Diclofenac Hexal?

Yes, official safety information explicitly addresses the ability to drive. If a user experiences side effects such as dizziness, vertigo, or drowsiness, official safety information states that they should avoid driving or operating machinery.

Q: Can using Diclofenac Hexal affect the results of blood tests?

Official product information notes that using the medicine can lead to changes that are monitored via blood tests. Specifically, reports include elevations of one or more liver enzymes and certain changes in blood cell parameters (like counts of red or white blood cells).

Q: Is Diclofenac Hexal the same drug as Voltaren?

Diclofenac Hexal contains the active ingredient diclofenac, which is also the active ingredient found in the well-known medicine brand Voltaren. Both are trade names for the same core substance, but specific formulations, strengths, and inactive ingredients may vary between products.

Q: Do people commonly experience changes in mood with Diclofenac Hexal?

Official labeling includes reports of adverse reactions in the nervous system category. These reported changes include the possibility of experiencing depression, anxiety, and confusion.

Q: Is Diclofenac Hexal available without a prescription in some countries?

Due to official concerns about cardiovascular risk, regulatory authorities in some regions have mandated that oral Diclofenac must be prescription-only medicine (POM). However, depending on the country, the topical forms (like gels) may remain available without a prescription.

Q: Can Diclofenac Hexal be taken with antacids or acid-reducing medicines?

Official safety information notes that certain antacids, specifically those containing aluminum or citrate, may potentially increase the absorption of aluminum. This combination requires oversight, particularly in patients with kidney issues.

Q: Can Diclofenac Hexal cause water retention or swelling?

Yes, regulatory safety information explicitly states that fluid retention and the resulting edema (swelling) have been reported in association with the use of NSAIDs like diclofenac.

Q: Is Diclofenac Hexal effective for muscle strains?

The approved indications for diclofenac often include the management of post-traumatic pain, inflammation, and swelling. These indications are associated with the types of symptoms commonly presented by injuries such as muscle strains.

Q: What are the rules about using Diclofenac Hexal before or after surgery?

Official regulatory warnings state that medicines containing diclofenac are strictly contraindicated for pain treatment around a Coronary Artery Bypass Graft (CABG) surgery.

Q: What should I do if I notice unusual bleeding while using Diclofenac Hexal?

Safety information officially states that signs of bleeding, such as black stools or vomiting blood, require immediate medical attention.

Q: Can Diclofenac Hexal cause ringing in the ears (tinnitus)?

Although tinnitus (ringing in the ears) is not always listed as a common effect, regulatory reports mention ear pain and other nervous system effects. Non-clinical safety studies have also noted the potential for ototoxicity, which refers to effects on the ear and hearing.

How should Diclofenac Hexal be stored and disposed of?

Storage and Disposal Requirements

The storage of Diclofenac (Hexal) is strictly defined by regulatory guidelines to maintain product integrity and safety.

Official Storage Conditions

Requirement	Description
Temperature	Store below 25 C or below 30 C. Liquid formulations must be kept from freezing.
Protection	Store in the original container to protect from light and moisture.
Child Safety	Keep the medicine out of the reach of children.

Disposal Instructions

Unused or expired medicinal product must be disposed of in accordance with local requirements. Regulatory information notes that Diclofenac poses a risk to the aquatic environment. Patients should consult a healthcare professional or pharmacist regarding the proper disposal methods for any medicine no longer needed.

Diclofenac Hexal